These benefits, along with a earlier report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two support the concept of concentrating on ACKR3 as a novel method to modulate the opioid technique, which could open up new therapeutic avenues for opioid-similar Issues. Disclaimer: The above is https://carolynp955ruy4.activoblog.com/profile